Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Diabetes, Obesity & Metabolism
|
January 13, 2015
Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes
J-L Faillie, K B Filion, V Patenaude, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 13, 2014
Evaluation of a laparoscopic training program with or without robotic assistance
V Letouzey, S Huberlant, J L Faillie, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
November 5, 2011
[Reliability of the pulse contour analysis for cardiac output measurement for assessing the fluid responsiveness]
V Reubrecht, G Dingemans, A Gache, et al.
Revue Neurologique
|
February 17, 2007
[Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients]
N Gaillard, P Fabro-Perray, J-L Faillie, et al.
ESMO Open
|
November 21, 2023
Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study
J Colard-Thomas, C Manceron, C Duflos, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
March 1, 2013
[Functional MRI by general radiologists in prediction of side-specific extracapsular extension after radical prostatectomy: what value in daily practice?]
A D Foahom Kamwa, P Costa, L Soustelle, et al.
Gynecologie, Obstetrique & Fertilite
|
October 31, 2006
[In vitro fertilization and smoking: use of urinary cotinine and expired air carbon monoxide measurements]
G Triopon, M-L Tailland, J-L Faillie, et al.
La Revue De Medecine Interne
|
January 24, 2021
[Management of immune-related toxicities associated with immune checkpoints inhibitors: Data from the multidisciplinary meeting « ToxImmun » in Eastern Occitania]
V Rivet, X Quantin, J L Faillie, et al.
Diabetes & Metabolism
|
October 18, 2016
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
M B Rehman, B V Tudrej, J Soustre, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Diabetes, Obesity & Metabolism
|
January 13, 2015
Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes
J-L Faillie, K B Filion, V Patenaude, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 13, 2014
Evaluation of a laparoscopic training program with or without robotic assistance
V Letouzey, S Huberlant, J L Faillie, et al.
Annales Francaises D'Anesthesie Et De Reanimation
|
November 5, 2011
[Reliability of the pulse contour analysis for cardiac output measurement for assessing the fluid responsiveness]
V Reubrecht, G Dingemans, A Gache, et al.
Revue Neurologique
|
February 17, 2007
[Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients]
N Gaillard, P Fabro-Perray, J-L Faillie, et al.
ESMO Open
|
November 21, 2023
Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study
J Colard-Thomas, C Manceron, C Duflos, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
March 1, 2013
[Functional MRI by general radiologists in prediction of side-specific extracapsular extension after radical prostatectomy: what value in daily practice?]
A D Foahom Kamwa, P Costa, L Soustelle, et al.
Gynecologie, Obstetrique & Fertilite
|
October 31, 2006
[In vitro fertilization and smoking: use of urinary cotinine and expired air carbon monoxide measurements]
G Triopon, M-L Tailland, J-L Faillie, et al.
La Revue De Medecine Interne
|
January 24, 2021
[Management of immune-related toxicities associated with immune checkpoints inhibitors: Data from the multidisciplinary meeting « ToxImmun » in Eastern Occitania]
V Rivet, X Quantin, J L Faillie, et al.
Diabetes & Metabolism
|
October 18, 2016
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials
M B Rehman, B V Tudrej, J Soustre, et al.
Page
of 1